NewsRx

Search our medical news database

Clinical Trials Week

Susan Hasty, Publisher

Table of Contents . . . May 12th, 2008

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Clinical Trials Week | Other Publications

Clinical Trial Research - Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845

Diabetes - Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections

Lung Cancer - Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer

Lupus - Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies

Memory Pharmaceuticals Corp. - Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454

Nymox Pharmaceutical Corporation - Nymox Announces New Positive Results at 54 Months in Long Term Study of NX-1207 for Benign Prostatic Hyperplasia

Acute Myelogenous Leukemia - Reports outline acute myelogenous leukemia research from University of Medicine and Dentistry of New Jersey

Adenocarcinoma - Research from Cornell University provide new insights into adenocarcinoma

Adverse Drug Reactions - Study results from Princess Margaret Hospital broaden understanding of adverse drug reactions

Atrial Fibrillation - Scientists at University of Montreal target atrial fibrillation

Breast Cancer - New breast cancer research reported from Duke University

Breast Cancer - New breast cancer study findings reported from L.Y. Dirix and co-authors

Breast Cancer - Researchers at Osaka National Hospital publish new data on breast cancer

Breast Cancer - Studies from National Cancer Institute yield new data on breast cancer

Breast Cancer - Study results from University of Texas update understanding of breast cancer

Cancer - New cancer research has been reported by R.J. Amato et al

Cancer - New findings from National Cancer Institute in the area of cancer published

Cancer Vaccines - Research on cancer vaccines described by D. Atanackovic and colleagues

Cancer Vaccines - Research reports on cancer vaccines from E.N. Vinageras and colleagues provide new insights

Chronic Lymphocytic Leukemia - Studies from University of Texas provide new data on chronic lymphocytic leukemia

Clinical Trial Research - Research from Queen's University broadens understanding of clinical trial research

Clinical Trial Research - Research from University of California reveals new findings on clinical trial research

Cord Blood - Data on cord blood discussed by R.L. Haspel and colleagues

Epilepsy - Studies from University of California yield new data on epilepsy

Gastrointestinal Stromal Tumors - Data from C.D. Blanke et al provide new insights into gastrointestinal stromal tumors

Hormones - Data from J. Spona et al provide new insights into hormones

Lung Cancer - Research on lung cancer detailed by scientists at University of Maryland

Mesothelioma - Studies from Brigham and Women's Hospital provide new data on mesothelioma

Monoclonal Antibodies - Data on monoclonal antibodies described by researchers at Duke University

Monoclonal Antibodies - Research results from University of Texas update knowledge of monoclonal antibodies

Monoclonal Antibodies - Study results from University of Paris provide new insights into monoclonal antibodies

Myeloid Leukemia - New research on myeloid leukemia from University of Texas summarized

Non-Hodgkin Lymphoma - Data on non-hodgkin lymphoma described by researchers at University of Rochester

Non-Hodgkin Lymphoma - Research from A. Krishnan and co-authors in the area of non-hodgkin lymphoma published

Non-Small Cell Lung Cancer - Findings from University of North Carolina in non-small cell lung cancer reported

Non-Small Cell Lung Cancer - New findings from Y. Oh and co-researchers in the area of non-small cell lung cancer described

Non-Small Cell Lung Cancer - Reports by R. Lilenbaum and co-researchers describe recent advances in non-small cell lung cancer

Non-Small Cell Lung Cancer - Research reports from N.A. Rizvi and co-authors provide new insights into non-small cell lung cancer

Non-Small Cell Lung Cancer - Study results from H. Kunitoh and colleagues update understanding of non-small cell lung cancer

Ovarian Cancer - Research from University of California provide new insights into ovarian cancer

Pancreatic Cancer - Research from Northwestern University yields new data on pancreatic cancer

Small Cell Lung Cancer - Study findings on small cell lung cancer are outlined in reports from Johns Hopkins University

Solid Cancer - Research on solid cancer published by scientists at Indiana University

Adenovirus - Research from University of Pittsburgh, Pittsburgh Cancer Institute reveals new findings on adenovirus

Cancer Therapy - Recent findings from Mayo Clinic highlight research in cancer therapy

Cancer Therapy - Reports outline cancer therapy study results from University of Cagliari, Department of Medical Oncology

Cancer Therapy - Research results from Technical University of Munich, Department of Medicine update knowledge of cancer therapy

Cancer Vaccines - Data on cancer vaccines reported by researchers at University of Virginia, Division of Surgical Oncology

Central Nervous System Disorders Therapy - Studies from Duke University, Department of Medical Oncology have provided new data on central nervous system disorders therapy

Melanoma Clinical Trial - Data on melanoma clinical trial published by researchers at University Hospital, Department of Dermatology

Melanoma Therapy - Studies from University of Montpellier, Department of Dermatology reveal new findings on melanoma therapy

Nephrectomy - Investigators at Medical University of Vienna zero in on nephrectomy

Non-Small Cell Lung Cancer Therapy - New non-small cell lung cancer therapy study findings recently were published by researchers at Chinese University of Hong Kong, Cancer Institute

Prostate Cancer Therapy - Research from University of Wisconsin, Comprehensive Cancer Center yields new findings on prostate cancer therapy

Accentia Biopharmaceuticals, Inc. - SinuNase Fast-Tracked Pivotal Phase 3 Study in Chronic Sinusitis Shows Statistically Significant Objective Evidence of Superiority of SinuNase Over Control Lavage in Severe Cases

Acorda Therapeutics, Inc. - Acorda Therapeutics Reports First Quarter 2008 Financial Results

Alexza Pharmaceuticals, Inc. - Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting

Amgen - Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory Committee Meeting in June

AmpliMed Corporation - AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer

Antigenics Inc. - Antigenics Reports First Quarter 2008 Financial Results

Apotex Inc., Kwizda Pharma GmbH and Intas Biopharmaceuticals Limited - Biosimilar G-CSF: Cooperation on Three Continents.

BioLineRx Ltd. - BioLineRx Presents BL-1020 Phase 2a Data at Society of Biological Psychiatry 63rd Annual Scientific Convention & Meeting

Breast Cancer - Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial

Bronchiectasis - Regulatory Path for Bronchitol in Bronchiectasis

Cambridge Consultants - Cambridge Consultants Offers Fast Track to Phase I Clinical Trials for Inhalable Drugs with Development Support for Conix

Cancer - Alan S. Schwartz Elected Chair, Karmanos Cancer Institute Board of Directors

Cancer - Oncothyreon files investigational new drug application for PX-866 oncology compound

Cancer Vaccines - Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas

Clinical Trial Research - Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)

Coagulation - Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172

Cougar Biotechnology, Inc. - Cougar Biotechnology Announces Initiation of Phase III Trial of CB7630 Abiraterone Acetate

Curis, Inc. - Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer

Curis, Inc. - Curis Reports First Quarter 2008 Financial Results

Emergent BioSolutions Inc. - Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate and Technology

Hepatitis C Virus - Clinical Update - Debio 025 in Hepatitis C

Hepatitis C Virus - Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

Hepatitis C Virus - Roche's Investigational Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Response in Phase IIa Study

KaloBios Pharmaceuticals, Inc. - KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003

Kosan Biosciences Incorporated - Kosan Announces First Quarter 2008 Financial Results

La Jolla Pharmaceutical Company - La Jolla Pharmaceutical Company Reports First Quarter Financial Results

Lupus - Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus

Lux Biosciences, Inc. - Lux Biosciences' Presentations at ARVO Highlight Both Topical and Polymer Delivery Technologies Targeting Chronic Inflammatory Ocular Diseases

Marketing and Licensing Agreements - Neuromed Names Sean Cunliffe Chief Commercial Officer

Medtronic, Inc. - Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies

Melanoma - Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab

Metabasis Therapeutics, Inc. - Metabasis Therapeutics Announces Positive Results in the Phase 2a Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes

Multiple Sclerosis - Merck Serono Announces Initiation of Phase II Clinical Trial of Atacicept in Relapsing Multiple Sclerosis

NACHA - International Payments Framework Now in Phase II

Nuon Therapeutics Inc. - Nuon Therapeutics Inc. Completes $27 Million Series B Financing

Oculus Innovative Sciences, Inc. - Oculus Innovative Sciences Announces Initial Chinese Commercialization Plan for Launch of Microcyn Technology

Panic Disorder - Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients

Protez Pharmaceuticals - Protez Initiates Phase II Study for Its Lead Product PZ-601 in Infectious Diseases

Pulmo BioTech Inc. - Pulmo BioTech Announces Appointment of Chief Financial Officer

Regeneron Pharmaceuticals, Inc. - Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration

Schering-Plough Corporation - Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL

Small Cell Lung Cancer - Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors

Type 2 Diabetes - Spherix D-tagatose to be Supplied by Inalco SpA

ZymoGenetics, Inc. - Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis

ZymoGenetics, Inc. - ZymoGenetics Presents Positive Results from RECOTHROM Thrombin, topical Recombinant Spray Study in Burn Patients

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook